ZAINAB ABDUL-RAHIM: Open Payments
NPI 1336521657 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 18 payments from 7 companies in 2025. Trend: 2023 $256 · 2024 $391 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $160 |
| Lilly USA, LLC | 2 | $145 |
| Gilead Sciences, Inc. | 4 | $85 |
| GlaxoSmithKline, LLC. | 3 | $43 |
| ViiV Healthcare Company | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
Products named: VIVITROL, ZEPBOUND, APRETUDE, PENMENVY, INGREZZA, GARDASIL 9, BEXSERO, ARISTADA.
Industry payments across IL — which companies pay providers there.
